WallStreetZenWallStreetZen

NYSE: PBH
Prestige Consumer Healthcare Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their PBH stock forecasts and price targets.

Forecast return on equity

Is PBH forecast to generate an efficient return?

Forecast return on assets

Is PBH forecast to generate an efficient return on assets?

PBH revenue forecast

What is PBH's revenue in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$1.2B+2.23%
Avg 2 year Forecast
$1.2B+4.86%
PBH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PBH revenue growth forecast

How is PBH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
2.4%
Industry
10.04%
Market
9.39%
PBH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PBH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PBH vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
PBH$68.35N/AN/A
ALVO$12.89$15.00+16.37%Buy
BHC$8.60$12.00+39.53%Hold
HCM$16.36$19.55+19.50%Buy
ALKS$23.76$35.43+49.11%Buy
View Top Pharmaceutical Stocks

Prestige Consumer Healthcare Stock Forecast FAQ

What is PBH's revenue growth forecast for 2025-2026?

(NYSE: PBH) Prestige Consumer Healthcare's forecast annual revenue growth rate of 2.4% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 10.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.39%.

Prestige Consumer Healthcare's revenue in 2024 is $1,134,235,000.On average, 3 Wall Street analysts forecast PBH's revenue for 2025 to be $57,572,122,782, with the lowest PBH revenue forecast at $57,483,945,646, and the highest PBH revenue forecast at $57,740,632,465.

In 2026, PBH is forecast to generate $59,051,621,915 in revenue, with the lowest revenue forecast at $58,918,810,070 and the highest revenue forecast at $59,184,433,760.

If you're new to stock investing, here's how to buy Prestige Consumer Healthcare stock.

What is PBH's forecast return on assets (ROA) for 2025-2026?

(NYSE: PBH) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.04%.

What is PBH's forecast return on equity (ROE) for 2025-2026?

(NYSE: PBH) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.